Skip to main content

Neurocrine Biosciences Inc

NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000914475

In the last 90 days, Neurocrine Biosciences Inc insiders filed 0 open-market purchases and 7 sales; 782 institutions reported holding it in 13F filings for Q2 2026, worth $17.0B in total; no superinvestor holds it.

Politicians who traded NBIX

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
4
Filings
3
Politicians
2
Buys / sells
2 / 2
Estimated volume
$32.0K
Sum of range midpoints
Politicians who traded NBIX
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
Lisa C. McClain House · MI
21 / 1$16.0KJun 17, 2025Aug 13, 2025
21 / 1$16.0KDec 21, 2020Jan 11, 2021

Trades

Reported trades in Neurocrine Biosciences Inc, newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
Lisa C. McClain House · MI
NBIXNeurocrine Biosciences, Inc. - Common StockSell (partial)SpouseJun 17, 2025Aug 13, 202557 daysLate$1K-$15KFiling
Lisa C. McClain House · MI
NBIXNeurocrine Biosciences, Inc. - Common StockBuySpouseJun 11, 2025Aug 13, 202563 daysLate$1K-$15KFiling
NBIXNeurocrine Biosciences, Inc.BuySelfDec 21, 2020Jan 11, 202121 days$1K-$15KFiling
NBIXNeurocrine Biosciences, Inc.Sell (partial)SelfJul 21, 2020Aug 19, 202029 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.